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Mouse model of rheumatoid arthritis
===================================

Adipue and colleagues \[[@B1]\] have characterized the novel IIJ (inherited inflamed joints) mouse strain, a new murine model of inflammatory, possibly autoimmune, arthritis that is similar both histologically and serologically to human rheumatoid arthritis (RA) and other murine models of autoimmune arthritis \[[@B1]\]. RA is a chronic and progressive inflammatory disorder characterized by synovitis and severe joint destruction. The pathogenesis of RA is a complex process, involving synovial cell proliferation and fibrosis, pannus formation, and cartilage and bone erosion \[[@B2]\]. Rodent models of RA have been used extensively to evaluate potential new therapeutic agents.

Arthritis in the mouse can be induced, can occur spontaneously in some inbred strains, or can result from single gene mutations (Table [1](#T1){ref-type="table"}). Induced murine arthritis models include immunization with type II collagen (DBA/1LacJ), or treatment with pristane (BALB/c), thymocytes (C3H/He), mycoplasma (CBA), or a high fat diet (C57BL). Spontaneous models can be grouped according to their origin: development of autoimmune-prone strains by selective mixing of previously existing inbred strains (for example, the MRL/lpr strain \[[@B3]\]); targeted gene manipulation (for example, the TCR trans-genic K/BxN model \[[@B4]\], TNF-α overexpression models \[[@B5]\], the IL-1Ra knock-out model \[[@B6]\], and the gp130Y759F-induced mutant); and identification of spontaneous mutants from breeding colonies (for example, SKG mice with a point mutation in Zap-70 \[[@B7]\]).

###### 

Animal models of arthritis

  Model                                   Abbreviation   Species                                           Feature
  --------------------------------------- -------------- ------------------------------------------------- ----------------------------------------------------------
  **Induced models**                                                                                       
   Non-specific immune stimuli                                                                             
    Adjuvant-induced arthritis            AA             Lewis rat                                         Autoimmune
    Oil-induced arthritis                 OIA            DA rat                                            Autoimmune
    Pristane-induced arthritis            PIA            DA ra                                             Autoimmune
   Cartilage directed autoimmunity                                                                         
    Collagen-induced arthritis            CIA            DBA mouse                                         CII AI
    Proteoglycan-induced arthritis        PGIA           Balb/c mouse                                      PG AI
   Infectious agents/exogenous triggers                                                                    
    Streptococcal cell wall arthritis     SCW-A          Lewis rat                                         Persistent bacteria AI
    Flare                                 SCW-F          Mouse                                             Th17
    Antigen-induced arthritis             AIA            Rabbit, mouse                                     Persistent antigen
    Flare                                 AIA-F          Mouse                                             Th17
                                                                                                           
  **Transgenic spontaneous models**                                                                        
   HTLV-induced arthritis                 HTLV           Mouse                                             Viral tax antigen
   KRN arthritis                          KRN            K/BxN mouse                                       GPI AI
   SKG arthritis                          SKG            Mouse                                             ZAP-70 T cell defect
   GP130 arthritis                        GP130          Mouse                                             STAT3, T cell defect
   TNF transgenic arthritis               TNFtg          Mouse                                             TNF overexpression
   IL-1ra transgenic arthritis            IL-1ra-/-      Balb/c mouse                                      Autoimmune T cells
   IL-1 transgenic arthritis              IL-1tg         Mouse                                             IL-1 overexpression
                                                                                                           
  **Immune complex models**                                                                                
   Collagen type II                       CAIA           DBA mouse                                         Mouse CII antibody
   KRN serum                              GPI            Balb/c mouse                                      Mouse GPI antibody
   Poly-L-lysine-lysozyme                 PLL-L          DBA mouse                                         Cationic antigen
                                                                                                           
  **New animal model**                                                                                     
   Spontaneous                                                                                             
    Inherited inflamed joints strain      IIJ            Arthritic male mouse crossed with SJL/J females   Autoimmune arthritis (for understanding the female bias)

AI, autoimmunity; CII, collagen type II; GPI, glucose-6-phosphate isomerase; HTLV, human T-lymphotropic virus; IL, interleukin; KRN, C57Bl/6 mice carrying the KRN transgene heterozygously; PG, proteoglycan; SKG, SKG strain, derived from closed breeding colony of BALB/c mice, spontaneously develops chronic arthritis; TNF, tumor necrosis factor.

Despite the existence of all of these models, it is well known that no animal model represents RA in its entirety. In addition, clinical manifestations are different between different strains of mice, even if the same induction protocol is employed, and some of the strains are even selected because of their susceptibility to auto-immunity. Even though it is improbable that a single animal model could assume and reproduce human disease in its entirety and consistently, animal models have allowed us to understand common principles of the induction and persistence of inflammatory processes and the pathways involved in cartilage and bone erosion and, therefore, have helped identify new therapeutic targets (Table [2](#T2){ref-type="table"}).

###### 

Drugs used to treat arthritis

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Type of drug                                             Name of drug                                                                                                                                                                                                    Use
  -------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------
  Drugs that affect symptoms of the disease (analgesics)   Acetaminophen\                                                                                                                                                                                                  Relieves pain\
                                                           Aspirin                                                                                                                                                                                                         Reduces inflammation and relieves pain

  Oral nonsteroidal anti-inflammatory drugs (NSAIDs)       Diclofenac\                                                                                                                                                                                                     Reduces inflammation and relieves pain\
                                                           Diflunisal, etodolac, fenoprofen, flurbiprofen, ibuprofen, indomethacin, ketoprofen, meclofenamate, mefenamic acid, meloxicam, nabumetone, naproxen, oxaprozin, phenylbutazone, piroxicam, sulindac, tolmetin   All NSAIDs treat the symptoms and decrease inflammation but do not alter the course of the disease

  COX-2 inhibitors                                         Celecoxib, valdecoxib                                                                                                                                                                                           Reduces inflammation and relieves pain

  Narcotic/analgesics                                      Propoxyphene\                                                                                                                                                                                                   Relieves pain\
                                                           Tramadol                                                                                                                                                                                                        Relieves pain

  Corticosteroids                                          Methylprednisolone, prednisone, injectable corticosteroids                                                                                                                                                      Suppresses inflammation in severe organ disease or life-threatening disease

  Disease-modifying antirheumatic drugs (DMARDs)^a^        Auranofin (oral gold), cyclosporine, gold salts (injectable), hydroxychloroquine, leflunomide, methotrexate, penicillamine, sulfasalazine                                                                       All DMARDs can slow progression of joint damage as well as gradually decrease pain and swelling

  Biologics                                                                                                                                                                                                                                                                

   Anti-TNF compounds                                      Adalimumab, etanercept, infliximab, certolizumab, golimumab                                                                                                                                                     Suppresses inflammation and inhibit the progress of joint damage

   IL-1 inhibitor                                          Anakinra                                                                                                                                                                                                        Treats moderate to severe RA in people who do not respond to DMARDs

   B-cell-depleting agent                                  Rituximab                                                                                                                                                                                                       Treats RA unresponsive to TNF inhibitors

   T-cell co-stimulation antagonist                        Abatacept                                                                                                                                                                                                       Treats RA unresponsive to DMARD therapy

   IL-6 antagonist                                         Tocilizumab                                                                                                                                                                                                     Treats RA unresponsive to TNF inhibitors
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

COX, cyclooxygenase; DMARD, disease-modifying anti-rheumatic drug; IL, interleukin; RA, rheumatoid arthritis; TNF, tumor necrosis factor.

Characterization of a novel and spontaneous mouse model of inflammatory arthritis
=================================================================================

Adipue and colleagues \[[@B1]\] describe a new strain of mouse that spontaneously develops a chronic inflammatory, possibly autoimmune, arthritis that shares many similarities with human RA and other mouse models of arthritis. The authors point out that arthritis incidence in IIJ mice also displays the sex bias common to many complex autoimmune diseases such as RA, multiple sclerosis, and systemic lupus erythematosus \[[@B8]\]. The sex bias appears to be specific for the arthritis phenotype since the incidence of typhlocolitis was similar between male and female IIJ mice. As most models reach 100% incidence in both sexes, no other spontaneous mouse model of arthritis has displayed such a sex bias, although more severe arthritis in females has been reported for both the SKG \[[@B7]\] and gp130Y759F models \[[@B9]\]. A female bias in incidence was also observed in collagen-induced arthritis in humanized HLA-DR4-transgenic mice \[[@B10]\] and was attributed to both hyperactive B cells and HLA-DR4 restricted antigen presentation in female mice and increased numbers of T and B regulatory cells in male mice \[[@B11]\]. In particular, Adipue and colleagues emphasize that the histopathology in IIJ mice is similar to that described in previously published mouse models of autoimmune arthritis \[[@B7],[@B9]\]. In addition, the predominantly neutrophilic and lymphocytic infiltration into the inflamed IIJ joints parallels the large numbers of neutrophils and T cells present in the inflamed synovial fluid of RA patients \[[@B12]\]. Finally, the IIJ mice also share serological similarities with RA and some other mouse models.

Conclusion
==========

Adipue and colleagues have identified the IIJ strain as a new murine model of inflammatory, possibly autoimmune, arthritis. The IIJ strain is similar both histologically and serologically to RA and other murine models of autoimmune arthritis. Moreover, the increased incidence of arthritis in female IIJ mice makes it a potentially important model to study the underlying causes of sex bias in autoimmunity.
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